TCN-032

TCN-032 · Theraclone Sciences, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TCN-032, covering 2012-11-01 to 2012-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Influenza Virus Challenge Study to Test Monoclonal Antibody TCN-032 as a Treatment for Influenza [Phase 2]